NEW YORK (GenomeWeb News) – The Albert Einstein College of Medicine of Yeshiva University will use funds from a $25 million private gift to establish an epigenomics research facility and to fund genetics and translational medical research.
The college said Tuesday it plans to use $7 million of the donation from Ruth and David Gottesman to start the Center for Epigenomics. Some of the money will support the Michael F. Price Center for Genetic and Translational Medicine, and $15 million will be used to start the David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.
Ruth Gottesman, a former faculty member at the college, was elected chair of Einstein's board of overseers in 2007.
The epigenomics center will be headed by Einstein researcher John Greally, who has developed a method for detecting the methylation patterns that characterize breast tumors and other cancers.
The college also said that it will use $3 million to start a Clinical Skills Facility.
"In discussions with the college, we determined that stem cells, epigenomics and clinical training were areas where we could help make an important contribution, both to Einstein and to the future of biomedical research," Ruth Gottesman said in a statement.
The Price Center for Genetic and Translational Medicine is scheduled to open in June 2008.